An audit of a Multistep Quality Improvement Initiative to Enhance Patient Safety After Sugammadex Administration to Female Patients Using Hormonal Contraceptives

( Can J Anesth/J Can Anesth . 2025;72:508–510. doi: 10.1007/s12630-025-02917-3) This article outlines a quality improvement initiative aimed at enhancing patient safety for women who receive sugammadex (SUG), a neuromuscular blockade reversal agent for aminosteroid muscle relaxants. SUG can interfere with the effectiveness of hormonal birth control, posing a risk of unintended pregnancy for those taking these medications. Despite this, patient counseling on the interaction is often inconsistent, especially postoperatively, when patient recall may be compromised. Concern also exists regarding anesthesiology team knowledge on the topic. To address these issues, the authors implemented a multistep strategy to improve staff awareness and patient education.